You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Deferiprone

Showing 26 - 50 of 74
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Heart Failure Trial in Lausanne, London (Dapagliflozin tablet, Empagliflozin Tablets)

Not yet recruiting
  • Heart Failure
  • Dapagliflozin tablet
  • Empagliflozin Tablets
  • Lausanne, VD, Switzerland
  • +2 more
Aug 24, 2023

Transfusion-dependent Thalassemia, Non-transfusion-dependent Thalassemia Trial in Worldwide (Deferasirox dispersable tablet

Completed
Has Results
  • Transfusion-dependent Thalassemia
  • Non-transfusion-dependent Thalassemia
  • Deferasirox dispersable tablet (DT)
  • Deferasirox film coated tablet (FCT)
  • Alexandria, Egypt
  • +16 more
Sep 6, 2021

Mild Cognitive Impairment Trial in San Antonio (Deferiprone, Placebo phase)

Withdrawn
  • Mild Cognitive Impairment
  • Deferiprone
  • Placebo phase
  • San Antonio, Texas
    University of Texas Health Science Center
Feb 5, 2018

Brain Aneurysms: Utility of Cisternal Urokinase Irrigation

Completed
  • Subarachnoid Hemorrhage, Aneurysmal
  • +2 more
  • Valencia, Spain
    Hospital General Universitario de Valencia
Mar 7, 2021

COVID-19 Trial in Kermanshah (Deferoxamine)

Unknown status
  • COVID-19
  • Kermanshah, Iran, Islamic Republic of
    Regenerative Medicine Research Center, Kermanshah University of
Apr 30, 2020

Cardiovascular Diseases, Heart Diseases, Beta-Thalassemia Trial in United States (Deferoxamine, Deferiprone (L1))

Terminated
Has Results
  • Cardiovascular Diseases
  • +2 more
  • Los Angeles, California
  • +5 more
Feb 1, 2018

Erythrocyte Transfusion, Beta-Thalassemia Trial in Worldwide (Luspatercept, Placebo)

Completed
Has Results
  • Erythrocyte Transfusion
  • Beta-Thalassemia
  • Los Angeles, California
  • +72 more
Jan 21, 2022

Friedreich Ataxia Trial (gamma interferon)

Completed
  • Friedreich Ataxia
  • gamma interferon
  • (no location specified)
Feb 25, 2020

ALS (Amyotrophic Lateral Sclerosis), Iron Overload Trial in Lille (Deferiprone)

Completed
  • ALS (Amyotrophic Lateral Sclerosis)
  • Iron Overload
  • Deferiprone
  • Lille, France
    Hôpital Roger Salengro, CHRU de Lille
Mar 8, 2017

Chronic Iron Overload Trial in Cyprus, Egypt, Italy (Deferiprone, dose level 1, Deferiprone, dose level 2, Deferiprone, dose

Completed
Has Results
  • Chronic Iron Overload
  • Deferiprone, dose level 1
  • +2 more
  • Nicosia, Cyprus
  • +6 more
Nov 11, 2016

Bioequivalence Trial in Erfurt (Deferiprone 500Mg Tablet, Deferiprone 500 MG Oral Tablet [Ferriprox])

Completed
  • Bioequivalence
  • Deferiprone 500Mg Tablet
  • Deferiprone 500 MG Oral Tablet [Ferriprox]
  • Erfurt, Thüringen, Germany
    SocraTec R&D GmbH Clinical Pharmacology Unit
Dec 6, 2016

Iron Mediated Vascular Disease in Sickle Cell Anemia Patients

Completed
  • Sickle Cell Disease
    • Los Angeles, California
      Children's Hospital Los Angeles
    Jan 9, 2019

    Diabetes, Iron Metabolism Disorders, Gastroduodenal Ulcer Trial in Jerusalem (Deferiprone, Acetylcysteine, Sitagliptin and

    Unknown status
    • Diabetes Mellitus
    • +5 more
    • Deferiprone
    • +2 more
    • Jerusalem, Israel
      Hadassah medical center
    Aug 24, 2016

    Beta Thalassemia Major Anemia Trial in Cairo. (Metformin)

    Unknown status
    • Beta Thalassemia Major Anemia
    • Cairo., Egypt
    • +1 more
    Jul 16, 2018

    Healthy Trial in Mount-Royal (Deferiprone delayed release tablet formulation, Deferiprone oral solution)

    Completed
    Has Results
    • Healthy
    • Deferiprone delayed release tablet formulation
    • Deferiprone oral solution
    • Mount-Royal, Quebec, Canada
      Algorithme Pharma Inc.
    Apr 8, 2016

    Healthy Trial in Toronto (Deferiprone sustained-release, Deferiprone immediate-release)

    Completed
    Has Results
    • Healthy
    • Deferiprone sustained-release
    • Deferiprone immediate-release
    • Toronto, Ontario, Canada
      Apotex Inc. BioClinical Development
    Apr 14, 2016

    Asymptomatic HIV Infection Trial in Port Elizabeth, Pretoria (Intravenous deferiprone, Placebo)

    Completed
    • Asymptomatic HIV Infection
    • Intravenous deferiprone
    • Placebo
    • Port Elizabeth, Eastern Cape, South Africa
    • +1 more
    Jun 3, 2016

    Healthy Trial in Mount-Royal (Deferiprone extended release, Deferiprone immediate release)

    Completed
    Has Results
    • Healthy
    • Deferiprone extended release
    • Deferiprone immediate release
    • Mount-Royal, Quebec, Canada
      Algorithme Pharma Inc.
    Jan 27, 2016

    Thalassemia Trial in Karachi (Standard Chelation, Amlodipine)

    Completed
    • Thalassemia
    • Karachi, Sindh, Pakistan
      Aga Khan University Hospital
    Jun 28, 2017

    Beta-Thalassemia, Hemosiderosis Trial in Worldwide (deferasirox)

    Completed
    • Beta-Thalassemia
    • Hemosiderosis
    • Cairo, Egypt
    • +4 more
    Feb 28, 2017

    Transfusional Iron Overload Trial in Greece, Italy, United States (ICL670)

    Completed
    • Transfusional Iron Overload
    • Oakland, California
    • +17 more
    Feb 21, 2017

    Sickle Cell Disease Trial in Montreal (single 1500 mg dose of Ferriprox)

    Completed
    Has Results
    • Sickle Cell Disease
    • single 1500 mg dose of Ferriprox
    • Montreal, Quebec, Canada
      CHUM-Hôpital Notre-Dame
    Jul 22, 2015

    Healthy Volunteers Trial in Mont-Royal (Deferiprone, Placebo)

    Completed
    Has Results
    • Healthy Volunteers
    • Deferiprone
    • Placebo
    • Mont-Royal, Quebec, Canada
      Algorithme Pharma Inc.
    Dec 4, 2014

    Prolonged QTc Interval Trial in Tempe (Deferiprone, deferiprone matching tablets, moxifloxacin)

    Completed
    Has Results
    • Prolonged QTc Interval
    • Deferiprone
    • +3 more
    • Tempe, Arizona
      Celerion
    Nov 7, 2014

    Beta Thalassemia Major Trial in Cairo (Deferiprone)

    Unknown status
    • Beta Thalassemia Major
    • Deferiprone
    • Cairo, Egypt
      Pediatric Hematology clinic, Ain Shams University
    Jan 13, 2015